HEALTH● LOWJul 30 · Jul 30, 2026, 5:26 PM
BMS granted FDA review for label expansion of Merck-partnered anemia therapy
Seeking Alpha Tech
BMS has received FDA review approval for expanding the label of its anemia therapy, developed in partnership with Merck. This marks a regulatory step forward for the pharmaceutical product.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH33m agoEbola: NCDC urges hospitals to act before laboratory confirmationPremium TimesHEALTH54m agoFree medical camp held for construction workers in VelloreThe HinduHEALTH58m agoEbola: NCDC warns misinformation could undermine Nigeria’s responsePremium TimesHEALTH1h agoEbola: NCDC approves ₦100,000 weekly allowance for quarantined contactsPremium Times